The board of directors of Novozymes has appointed Peder Holk Nielsen as president and CEO of the company, with his position going into effect on April 1, 2013, succeeding current president and CEO Steen Riisgaard.


Nielsen has played a central role in the development of Novozymes in its current form, according to the company. He is currently serving as executive vice president and head of enzyme business, a position he has held since 2007. Prior to this, Nielsen’s career spanned management positions in Novozymes and Novo Industri/Novo Nordisk across business development, R&D, quality management and sales and marketing.